reconstitute 100 mg ghk cu GHK-Cu — Slimfit Compounds GHK-Cu Peptide (100mg) for Research

At 2.4 mg, the target dose for phase 3 trials, the benefit-to-risk ratio appeared optimal

Phase I awards typically range from $150,000 to $250,000 and cover a period of six months to a year

Claudin-1 overexpression in intestinal epithelial cells enhances susceptibility to adenamatous polyposis coli-mediated colon tumorigenesis

An increase in the levels of circulating variant-specific nAbs was observed in mice vaccinated with pCTV-WS and challenged with either the Gamma or Omicron variants

Backwash A process in which flow is reversed through a filter to remove accumulated solids, biofilm, and debris, restoring filtration performance